The primary authors are a group of five health professionals who decided to work together on the basis of shared concern. Our effort and this website represent solely our own work and we have not obtained support from biomedical or health interests, or patient advocacy groups.
Daniel P. Alford, MD, MPH is Professor of Medicine, Associate Dean of Continuing Medical Education and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine. He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is past-president of the Association for Medical Education and Research in Substance Abuse. In 2011 he was recognized as a “Champion of Change” by the White House. He has received the American Medical Association’s “Award for Health Education”, the American Society of Addiction Medicine first “Educator of the Year Award” and the American College of Physicians “Award for Distinguished Contributions to Behavioral Medicine”. His SCOPE of Pain education program was presented the Office of National Drug Control Policy’s “Outstanding Prevention Effort” award. His clinical, educational and research interests focus on opioid use disorders and safer and more competent opioid prescribing for chronic pain.
Disclosure: Daniel P. Alford serves as course director and faculty for safe opioid prescribing CME funded by an unrestricted educational grant awarded to Boston University by the REMS Program Companies as part of the FDA's Opioid REMS program. He has not received any direct payment from industry for this activity.
Dr. Richard Dart is an emergency medicine physician and toxicologist who directs the Rocky Mountain Poison and Drug Center. He is the Executive Director of Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS®) System. He has published more than 300 papers, chapters and books. He also serves as a Deputy Editor of the medical journal Annals of Emergency Medicine and is past-president of the American Association of Poison Control Centers.
Disclosure: Richard Dart is Executive Director of the RADARS System. Most manufacturers of prescription opioids or stimulants subscribe to RADARS System which is the property of Denver Health and Hospital Authority, a political subdivision of the State of Colorado.
James DeMicco, PharmD is Adjunct Professor at Long Island University College of Pharmacy and Pharmacist in Charge of J&J Pharmacy in Hackensack, NJ. He has worked in community pharmacy for over 15 years. In 2009, he established a new community pharmacy in Hackensack specializing in pain management and addiction. James has a collaborative practice agreement with an addiction psychiatrist and provides continuing education programs for pharmacist in conjunction with the NJ Pharmacist Association.
Disclosure: James DeMicco is a pharmacist in charge of a community pharmacy and reports no other conflicts of interest.
Stefan G. Kertesz, MD, MSc is a physician in internal medicine and addiction medicine. Presently based at the Birmingham Veterans Affairs Medical Center, he is also Professor at University of Alabama at Birmingham School of Medicine. He has a 22-year history of providing primary care for individuals who are homeless or similarly vulnerable, and researching health services and epidemiology related to substance use and homelessness, supported by research awards from the National Institute on Drug Abuse (2002-2012) and the Veterans Affairs Health Services Research & Development Branch (2008-2018). He has published research and commentaries in JAMA, New England Journal of Medicine, Addiction, Medical Care, and the American Journal of Public Health. Dr. Kertesz grew up in Sunnyvale, California. He penned his first reflections on homelessness for his high school newspaper, the Homestead Epitaph, in 1984. Views are his own, and do not reflect positions of any federal or state employer.
Disclosure: Stefan G. Kertesz attests to prior personal ownership of stock in Abbot and Merck, not exceeding 3% of his assets, sold in December of 2017. He reports no other contracts, honoraria, grants or relationships to biomedical industries now or in the past.
Dr. Sally Satel is a resident scholar at AEI and the staff psychiatrist at a local methadone clinic in D.C. Dr. Satel was an assistant professor of psychiatry at Yale University from 1988 to 1993 and remains a lecturer at Yale. From 1993 to 1994 she was a Robert Wood Johnson policy fellow with the Senate Labor and Human Resources Committee. She serves on the National Advisory Council of the Substance Abuse and Mental Health Services Administration, HHS. Dr. Satel has written widely in academic journals on topics in psychiatry and medicine, and has published articles on cultural aspects of medicine and science in numerous magazines and journals. She has testified before Congress on veterans’ issues, mental health policy, drug courts,and health disparities. Dr. Satel is author of Drug Treatment: The Case for Coercion (AEI Press, 1999), and PC, M.D.: How Political Correctness Is Corrupting Medicine (Basic Books, 2001). She is coauthor of One Nation under Therapy (St. Martin’s Press, 2005), co-author of The Health Disparity Myth (AEI Press, 2006), and editor of When Altruism Isn’t Enough: The Case for Compensating Kidney Donors (AEI Press, 2009). Her recent book, co-authored with Emory psychologist Scott Lilienfeld is Brainwashed: The Seductive Appeal of Mindless Neuroscience (Basic, 2013).Brainwashed was a finalist for the 2013 Los Angeles TimesBook Prize in Science.
Disclosure: Sally Satel is at the American Enterprise Institute and a lecturer at Yale University School of Medicine; she reports no other contracts, honoraria, grants or relationships to biomedical industries now or in the past.